Commissioned research by Vator Securities is offered to selected life science companies – “By Invitation Only”
Commissioned research: Immunovia AB
Immunovia is a Swedish-based diagnostic company in late-stage development for products for early detection of diseases within the oncology and autoimmune areas, with a primary target on early detection of pancreas cancer.
The company’s management team has extensive diagnostics company background, including GE Healthcare and DAKO (aquired by Agilent)
Commissioned research: AlzeCure Pharma
AlzeCure Pharma is a Swedish-based pharmaceutical company with potentially first-in-class proprietary and novel targeted small molecule (tablets) candidates for neurodegenerative diseases with a primary target on Alzheimer’s Disease (AD).
AlzeCure’s management team has extensive big pharma experience, and formed an integral part of AstraZeneca’s CNS department.